Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer

Published:2012-08 Issue:2 Volume:77 Page:346-352
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ahn Myung-Ju,Yang James Chih-Hsin,Liang Jun,Kang Jin-Hyoung,Xiu Qingyu,Chen Yuh-Min,Blair Julie Michelle,Peng Guangbin,Linn Carlos,Orlando Mauro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

3. Duration of first-line chemotherapy is advanced non-small-cell lung cancer: less is more in the era of effective subsequent therapies;Socinski;J Clin Oncol,2007

4. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small cell lung cancer: a randomised, double-blind, phase 3 study;Ciuleanu;Lancet,2009

5. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small cell lung cancer;Fidias;J Clin Oncol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Hypokalemia Incidence and Better Treatment Response in NSCLC Patients: A Meta-Analysis and Systematic Review on Anti-EGFR Targeted Therapy Clinical Trials;Frontiers in Oncology;2022-01-05

2. A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer;Medicine;2020-07-31

3. CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum;British Journal of Cancer;2020-05-25

4. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy;Molecular Cancer;2020-04-27

5. Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma;Thoracic Cancer;2018-12-05